ATX-GD-59

· Apitope International NV

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATX-GD-59, covering 2019-06-14 to 2019-06-14. Get the full timeline:

Most recent: Clinical Trial Update: ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy [Phase 1]